Background: The pain involved in orthodontic treatments may involve inflammatory processes. This study evaluated the effect of using a naproxen patch for pain reduction in the separating stage of fixed orthodontic treatment. Methods: In this double-blind, randomized, controlled clinical trial of 35 orthodontic patients (age: 14-19 years) who had pain during separator placement, each patient randomly placed naproxen and placebo patches in the first permanent molar region, in opposite quadrants of the same jaw. Patches were replaced every 8 hours until 3 days after separator placement. Patients recorded their pain perception at 2, 6, and 24 hours, and on days 2 (6 PM), 3 (10 AM and 6 PM), and 7 (10 AM and 6 PM), using a visual analog scale. Mean pain scores were compared for the two patches, and effects of sex and age thereon determined. Results: Data from 29 patients (21 girls, eight boys) were analyzed. Mean pain values decreased over time for both patches (P < 0.001). Recorded pain did not differ significantly between the sexes (P = 0.059) or between those aged <16 and those ≥16 years (P = 0.106). Mean pain recorded with naproxen patches was statistically significantly less than that with placebo patches at all time points (P = 0.004). Conclusion: The naproxen patch was more efficient than the placebo patch for reducing pain at all time points. The highest pain score was recorded at 6 hours, and the least pain was recorded at the 7 th day after separator placement.
INTRODUCTION
Most adult patients undergoing orthodontic treatment complain of experiencing various levels of orthodontic post-adjustment pain [1] . In a 1985 survey, focused on the attitudes of patients and parents toward orthodontic treatment, Oliver et al. reported that pain induced by the appliance is the major discouraging factor [2] . Another study reported that 30% of patients wanted to terminate the treatment solely because of the pain they experienced [3] . Furthermore, one of the main aspects of oral healthrelated quality of life is pain control [4] . Additionally, pain has a negative impact on oral hygiene [5] . It is not possible to predict the incidence and severity of pain experienced by the patient [6] . Ultimately the amount of satisfaction of the patient with the outcome of treatment is affected by the overall amount of pain experienced [7] .
The mechanism underlying the pain involved in orthodontic treatments is not fully understood. However, several explanations have been proposed. One explanation suggests that applying orthodontic forces to the teeth causes a release of inflammatory and proinflammatory mediators [8] . One of the key inflammatory mediators are prostaglandins, which act as a mediator for tooth movement but also increase pain and the transmission of pain stimuli [9] . Moreover, development of ischemic areas in the periodontal ligament undergoing sterile necrosis is thought to be related to the pain caused by the orthodontic treatment. There is a direct correlation between the force applied and the amount of pain the patient experiences, as larger forces create larger ischemic areas and therefore more pain [10] .
There are two objectives when controlling inflammation: pain relief and halting tissue destruction.
Transcutaneous electrical nerve stimulation, vibratory stimulation, low-level laser therapy [11] [12] [13] , using chewing gum or bite wafers [6] , application of local/topical anesthesia [14] , and oral administration of non-steroidal anti-inflammatory drugs (NSAIDs) [6] are among the methods that have been advocated for reduction of orthodontic pain. However, each of these methods has its disadvantages. For example, there is a possibility of tongue biting and lip burns secondary to the administration of local anesthetic agents, particularly in children; using NSAIDs in high doses may hinder tooth movement; and aside from difficulty experienced in chewing bite wafers or gum, such chewing may bend the orthodontic wires [15] .
Naproxen and naproxen sodium are effective nonsteroidal, anti-inflammatory analgesics marketed under the brand names Anaporax and Diocodal. It is absorbed in the gastrointestinal tract and metabolized by the liver, and has a plasma half-life of 12-15 hours and it is mainly excreted through urine. It may cause gastrointestinal bleeding, exacerbation of asthma attacks in asthmatic patients, and should be administered cautiously in patients having renal or hepatic disorders [16] .
The objective of this study was to evaluate the efficacy of a naproxen patch in decreasing pain after the placement of elastic separators in patients undergoing fixed orthodontic treatment. [17] . Initially, a pilot study was performed in order to assess the taste, durability, adhesion properties, and the appropriate way for using this patch. A total of six patients were enrolled in this pilot study and were not included in the main study. These patients were asked to place the patch on the gingival tissue of one of the permanent first molars and hold it there until the patch attached to the gingiva. Subsequently, the patients were A statistical analyst extracted the data from the questionnaires. Using the Kolmogorov-Smirnov test, the distribution of the data was evaluated and was found to be normal. Due to the existence of independent factors of time and the side of jaw to which the drug was applied, and non-independent factors of gender and age groups and the normal distribution of the data, a variance analysis parametric test was used. P < 0.05 were considered statistically significant. Pairwise comparisons of time points were made using the Bonferroni method. The differences in the severity of pain between males and females, and between patients younger than 16 old and ≥16 years, were analyzed using multifactorial repeatedmeasures analysis of variance (ANOVA).
METHODS

RESULTS
A total of 35 patients participated in this study. Six were excluded as they did not mention experiencing any Figs. 1 and 2 . Additionally, the Bonferroni method showed that there were significant differences between time points (Table 2) . Multifactorial repeated-
measures ANOVA was used to analyze the severity of pain between males and females and between age groups, and revealed that the level of pain was not significantly different between males and females (P = 0.059; Fig. 3 ) or between those aged <16 years or ≥16 years (P = 0.106; Because the aim of this study was to assess the analgesic efficacy of a certain drug, the patients were selected accordingly. Therefore, the inclusion criteria stipulated application of a certain amount of load to the first molars. In order to achieve this goal, these conditions had to be met: tight contact of first molars with the adjacent teeth, presence of opposing teeth on both sides, There was no significant difference in the level of pain experienced between males and females in this study (P = 0.059), which was in agreement with previous studies on this matter [14, 19, 31] . No significant difference was found between the two age groups (< 16, ≥ 16 years; P = 0.106). This may be due to the close proximity of the age range between these groups. The division of the age range was based on a recent study by Eslamian et al., in which the analgesic efficacy of 5% naproxen gel for pain associated with orthodontic separator placement was assessed [32] . They concluded that there was no difference between the age groups and that naproxen gel was effective for reducing pain caused by separator placement. Another study by Eslamian et al. in 2013 also
showed that there was no significant difference between <18 and >18 year age groups [9] . A further study by Based on the significant difference in the level of pain between the case and control groups at all time intervals except the 7th day, it can be concluded that the 5% naproxen patch is efficient for pain reduction in the first few days after separator placement. Moreover, the highest level of pain was recorded at 6 and 24 hours after separator placement and was reduced to its lowest level by the 7 th day.
